Simon A C, Levenson J A, Bouthier J, Maarek B, Safar M E
J Cardiovasc Pharmacol. 1985;7 Suppl 1:S45-51. doi: 10.1097/00005344-198507001-00010.
The effects of angiotensin-converting enzyme inhibition on large arteries have been examined in uncomplicated essential hypertensive patients (grade 1-2 WHO). These effects were determined from (a) changes in arterial compliance as measured from the slope of the decline in arterial pressure during diastole and (b) alterations in diameter of the brachial artery and blood flow velocity within its lumen, as assessed by pulsed Doppler velocimetry. Both acute and chronic ACE inhibition were accompanied by a significant increase in arterial compliance and a dilation of the brachial artery. This response might be related to changes in plasma and/or intraarterial angiotensin and/or to changes in plasma potassium. Whatever their mechanism, the arterial dilatation and increase in compliance would improve the buffering and the conducting functions of the large arteries, and these in turn may, if persistent, prove beneficial in possibly preventing arterial complications of hypertension.
已在无并发症的原发性高血压患者(世界卫生组织1-2级)中研究了血管紧张素转换酶抑制对大动脉的影响。这些影响是通过以下方式确定的:(a) 根据舒张期动脉压下降斜率测量的动脉顺应性变化,以及(b) 通过脉冲多普勒测速法评估肱动脉直径及其管腔内血流速度的改变。急性和慢性ACE抑制均伴有动脉顺应性显著增加和肱动脉扩张。这种反应可能与血浆和/或动脉内血管紧张素的变化和/或血浆钾的变化有关。无论其机制如何,动脉扩张和顺应性增加将改善大动脉的缓冲和传导功能,如果这种情况持续存在,反过来可能有利于预防高血压的动脉并发症。